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ABSTRACT
Perinatal asphyxia induces neuronal cell death and brain injury, and is often associated with irreversible
neurological deﬁcits in children. There is an urgent need to elucidate the neuronal death mechanisms
occurring after neonatal hypoxia-ischemia (HI). We here investigated the selective neuronal deletion of the
Atg7 (autophagy related 7) gene on neuronal cell death and brain injury in a mouse model of severe
neonatal hypoxia-ischemia. Neuronal deletion of Atg7 prevented HI-induced autophagy, resulted in 42%
decrease of tissue loss compared to wild-type mice after the insult, and reduced cell death in multiple
brain regions, including apoptosis, as shown by decreased caspase-dependent and -independent cell
death. Moreover, we investigated the lentiform nucleus of human newborns who died after severe
perinatal asphyxia and found increased neuronal autophagy after severe hypoxic-ischemic
encephalopathy compared to control uninjured brains, as indicated by the numbers of MAP1LC3B/LC3B
(microtubule-associated protein 1 light chain 3)-, LAMP1 (lysosomal-associated membrane protein 1)-, and
CTSD (cathepsin D)-positive cells. These ﬁndings reveal that selective neuronal deletion of Atg7 is strongly
protective against neuronal death and overall brain injury occurring after HI and suggest that inhibition of
HI-enhanced autophagy should be considered as a potential therapeutic target for the treatment of
human newborns developing severe hypoxic-ischemic encephalopathy.
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Introduction
Perinatal asphyxia-induced brain injury, frequently presenting
itself as hypoxic-ischemic encephalopathy (HIE), is one of the
most common causes of mortality and long-term neurological
impairments in term and preterm neonates, such as cerebral
palsy, mental retardation, visual and hearing deﬁciencies, learn-
ing disability, and/or epilepsy.1 This is due to lesions that are
found predominantly in the gray matter, including the basal
ganglia, thalamus and cortex.2
Although human studies are sparse and difﬁcult to per-
form, the neuronal cell death patterns in response to
hypoxia-ischemia (HI) have been reported to consist mostly
of necrotic, apoptotic and some hybrid features deﬁned as
the “cell death continuum.”3 Many studies have focused on
apoptosis as a therapeutic target for preventing neonatal HI
brain injury,4,5 but the prevention of neuronal apoptosis has
not yet been proven to be clinically relevant. Current thera-
peutic options for neonatal HIE are predominantly support-
ive and seek to maintain physiological parameters.
Exceptions to this are early post-insult hypothermia and
injections of recombinant human erythropoietin.6,7 The efﬁ-
cacy of these treatments, however, is limited, and an
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improved understanding of neuronal cell death mechanisms
after neonatal HI brain injury is needed to develop novel
treatments.
In rodents, the patterns of HI-induced neuronal cell death in
the immature brain conﬁrm the presence of mixed morpholog-
ical phenotypes involving necrotic, apoptotic, and autophagic
features, each of which corresponding to a unique set of bio-
chemical and morphological criteria.3, 8-11
Autophagy—which is activated by many forms of stress12—
is an important physiological mechanism for degrading long-
lived cytosolic protein complexes and aggregates and is the
only known pathway for degrading organelles.13 Autophagy
recycles amino acids and fatty acids to produce energy and
removes damaged organelles. Thus, basal autophagy plays an
essential role in cell survival.14,15 However inappropriate activa-
tion of autophagy can be directly involved in mediating cell
death or can trigger the execution of apoptotic or necrotic cell
death.16
The immature brain retains its autophagic machinery to a
larger extent than the adult brain, as judged by the levels of
LC3-II,11 as part of maintaining normal brain development.17,18
Several studies have reported the presence of enhanced neuro-
nal autophagy in rodent models of perinatal cerebral ischemia
or HI.11,19-24 Even if a death-mediating role of autophagy has
been demonstrated in most of these studies, as indicated by the
protective effects of inhibiting autophagy by both pharmaco-
logical and genetic methods,11,19,21-23,25 some studies have
reported a protective effect of pretreatment with the autophagy
inducer rapamycin.20,24
The present study aims to investigate the effect of selec-
tive autophagy inhibition in the pathology of rodent neona-
tal HI brain injury and provides strong evidence for a
prodeath role of HI-induced neuronal autophagy in differ-
ent cerebral regions. We used mice unable to execute
autophagy speciﬁcally in neurons due to a tissue-speciﬁc
deletion (or knockout) of the Atg7 gene (atg7 KO), which is
involved in autophagy induction and autophagosome for-
mation. A model of severe neonatal HI affecting most of
the brain was used to determine the effects of genetically
inhibited autophagy on neuronal cell death and brain
injury. Moreover, in order to determine whether autophagy
could also be involved in human HIE brain damage, we
investigated markers of autophagy in autopsied brain tissues
of human term newborns who died from severe asphyxia
with HIE focusing on the basal ganglia, a part of the brain
highly susceptible to HI injury.
Results
HI induces autophagy in neonatal mice
Twenty-four h after HI, immunoblot analysis revealed, as
expected, an increase in LC3B-II levels in the ipsilateral
hemisphere of Atg7ﬂox/C; Nes-Cre (Ctrl) mice, indicating an
increase in autophagosome formation (Fig. 1A, B). More-
over, immunohistochemistry for SQSTM1/p62 (a protein
that is selectively degraded during autophagy) shows a
reduction of neuronal SQSTM1 expression in the damaged
hemisphere (Fig. 1C). Ultrastructural studies clearly revealed
the formation of autophagosomes in dying neurons
(Fig. 1D) of Ctrl mice after HI. Altogether, these data indi-
cate that autophagy is increased in this mouse model of
neonatal HI.
Neuronal Atg7 deﬁciency prevents basal autophagy
without increasing stress-related proteins in neonatal mice
In order to investigate the speciﬁc role of neuronal
enhanced autophagy after HI, we characterized mice bearing
a neuron-speciﬁc knockout of Atg7 resulting from the inac-
tivation of ﬂoxed Atg7 by Cre recombinase expressed under
the Nes/nestin promoter (Nes-Cre; Atg7ﬂox/ﬂox). The Nes
promoter is commonly used when targeting brain neu-
rons.15 These mice display a nearly complete deﬁciency of
neuronal ATG7 protein, as well as defective autophagy, as
shown by the absence of LC3B-II (Fig. 2A) and pronounced
neuronal SQSTM1 accumulation (Fig. 2A to C) as early as
on postnatal d 9 (P9). Punctate SQSTM1-positive staining
was observed in neurons from the cortex, hippocampus,
and striatum of atg7 KO mice but not in Ctrl mice, which
presented a diffuse labeling (Fig. 2B).
We also veriﬁed that the expression of several cell death-
related proteins, such as AIFM1/AIF (apoptosis-inducing
factor, mitochondria associated), CYCS (cytochrome c,
somatic) and CASP3 (caspase 3), was not different between
atg7 KO and Ctrl mice (Fig. 2D). This indicates that, at the
time points investigated, the general apoptotic machinery
was transcriptionally intact and unaffected by the ATG7
deﬁciency. Mitochondria-related proteins, such as SOD2
(superoxide dismutase 2, mitochondrial), HSP70/heat shock
protein 70 kDa and CAT (catalase) as well as mitochondria
respiratory chain complexes were also similarly abundant in
atg7 KO and Ctrl mice (Fig. 2D). Thus, neuronal ATG7
deﬁciency impedes basal autophagy in P9 mice without
inducing cellular stress at young developmental stage. This
was further conﬁrmed by measuring the transcriptional lev-
els of Keap1-Nfe2l2-related genes (Keap1, Nfe2l2 and Gclc),
which are regulators of oxidative stress. Under physiological
conditions, the transcription of these genes was not differ-
ent in atg7 KO mice, indicating that higher levels of Keap1-
Nfe2l2 pathway-related genes does not explain the increased
resilience to HI (Fig. S1). GSR (glutathione reductase) cata-
lyzes the NADPH-dependent reduction of oxidized glutathi-
one to GSH/reduced glutathione, and thereby maintains
adequate levels of GSH. A high GSH/oxidized glutathione
ratio is essential for protection against oxidative stress. GSR
activity was measured both under control conditions and
after HI. GSR activity increased after HI, but the levels
were not different between Ctrl mice and atg7 KO mice,
neither under control conditions, nor after HI. These data
suggest that the protection against HI-induced neuronal
death after atg7 KO is not related to enhanced redox capac-
ity (Fig. S2). To further investigate if Atg7 deﬁciency has
effects on mitochondrial function, we examined the tran-
scription of the mitochondrial ﬁssion gene Dnm1l/Drp1,
and the fusion gene Mfn1 (Fig. S3), as well as 2 key mito-
chondrial biogenesis-related genes, Ppargc1a/Pgc1a and
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Nrf1. We also analyzed the mtDNA copy number. In atg7
KO mice (Fig. S4), none of these 4 genes was altered com-
pared with Ctrl mice, and mtDNA copy number was also
unaltered. These results suggest that mitochondrial biogene-
sis, ﬁssion and fusion, reﬂecting the mitochondrial life cycle,
were unaffected by atg7 KO.
Neuronal Atg7 deﬁciency reduced hypoxia-ischemia-
induced brain injury
The effects of neuronal Atg7 deﬁciency on HI-induced auto-
phagy and brain injury were evaluated. In atg7 KO mice, the
LC3B-II HI-dependent increase was completely prevented
(Fig. 3A). Furthermore, at the ultrastructural level, no autopha-
gosomes were observed in atg7 KO mice (data not shown) con-
ﬁrming that ATG7 deﬁciency efﬁciently prevented HI-induced
neuronal autophagy.
Eight d after neonatal HI, the histologically detectable
brain injury encompassed several areas in the cortex, hippo-
campus, striatum, and thalamus (Fig. 3B). The overall brain
injury volume—as indicated by tissue loss—was 55.1 §
4.5 mm3 in the Ctrl mice. Tissue loss was decreased by 42%
(32.0 § 5.0 mm3, p D 0.001) in the atg7 KO mice
(Fig. 3C). This protective effect was conﬁrmed by calculat-
ing the pathological scores of the different affected brain
areas (cortex, hippocampus, striatum, and thalamus)
(Fig. 3D). No signiﬁcant difference between males and
females was observed in tissue loss volume, neither in atg7
KO nor in Ctrl mice (Fig. 3E). Ultrastructural studies
revealed that the number of dying neurons (per visual ﬁeld)
with condensed chromatin in their nuclei was clearly
reduced in atg7 KO mice (86.3 § 3.5% in Ctrl and 20.9 §
3.4% in atg7 KO mice P < 0.0001, n D 6/group), indicating
that the neuronal architecture was more intact in atg7 KO
than in Ctrl mice (Fig. 3F).
Figure 1. Hypoxia-ischemia induces neuronal autophagy in neonatal Atg7ﬂox/C; Nes-Cre mice. (A) Representative immunoblotting of LC3B in Ctrl (Atg7ﬂox/C; Nes-Cre) mice and
(B) its corresponding quantiﬁcation showed that LC3B-II (16 kDa) was increased in the ipsilateral hemisphere (IL) 24 h after HI compared to an uninjured control brain,
(, P < 0.05, n D 6). (C) Immunostaining of SQSTM1 in the cortex of Ctrl mice suggesting a decrease of its staining in neurons (RBFOX3) 24 h after HI. (D) Dying neurons
in Ctrl mice exhibited increased electron density and nuclei with chromatin condensation. They possessed also typical autophagosomes with double membranes in the
perikarya (black arrowheads) 24 h after HI. Squared areas are enlarged in the right panels.
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Neuronal Atg7 deﬁciency decreased neuronal death in the
immature brain after hypoxia-ischemia
Neuronal cell death in the cortex and striatum as well as in the den-
tate gyrus (DG) and the cornu ammonis (CA) was investigated by
using Fluoro-Jade staining, a nonspeciﬁc neuronal marker of cell
death, 24 h after HI (Fig. 4A). The number of Fluoro-Jade-positive
neurons in all 4 cerebral regions was signiﬁcantly reduced in atg7
KO compared to Ctrl mice after HI (Fig. 4B to E).
Apoptotic cell death pathways, including caspase-dependent
and –independent pathways, were investigated by quantifying the
activation of CASP3 (Fig. 5A to E) and the mitochondrial-nuclear
translocation of AIFM (Fig. 6A to E). Immunohistochemical detec-
tion of active cleaved CASP3 (but not its inactive precursor, pro-
CASP3) revealed a similar pattern as that shown by Fluoro-Jade
staining (Fig. 4). Moreover, CASP3 enzymatic activity was 50%
lower in the ipsilateral hemispheres of atg7 KO compared to the
Ctrl mice 24 h after HI (Fig. 5F). CASP3 data were conﬁrmed by
immunoblotting against SPTAN1/a-fodrin, revealing a decrease in
the production of the caspase-dependent 120-kDa breakdown
product (Fig. 5G, E). Caspase-independent apoptotic cell death—
as indicated by AIFM1 nuclear translocation, as shown previ-
ously26—was also reduced in atg7 KO compared to Ctrl mice in all
brain regions (Fig. 6).
Neuronal Atg7 deﬁciency decreased hypoxia-ischemia-
induced inﬂammation
As neuroinﬂammation is involved in HI-induced cell death, we
investigated the effect of neuronal autophagy inhibition on
some inﬂammatory markers. The quantiﬁcation of selected
cytokines and chemokines, such as interleukins (IL1A [inter-
leukin 1 a], IL1B [interleukin 1 b], IL6 [interleukin 6], IL10
[interleukin10], TNF [tumor necrosis factor], CXCL1[chemo-
kine (C-X-C motif) ligand 1] and CCL2 [chemokine (C-C
motif) ligand 2]) in brain homogenates revealed that IL1B, IL6,
CXCL1 and CCL2 were less expressed in atg7 KO than Ctrl
mice 24 h after HI (Fig. 7A). After HI, microglial cells positive
for AIF1/IBA1 (allograft inﬂammatory factor 1), were activated
and accumulated in the injured area after HI, as indicated by
morphological examination (retracted processes and enlarged
cell bodies) (Fig. 7B) and double labeling with LGALS3/galec-
tin-3 (lectin, galactoside-binding, soluble, 3) (Fig. 7C). This
microglial recruitment was less extensive in atg7 KO mice com-
pared to Ctrl, as shown by quantiﬁcation of the number of
active AIF1-positive cells (Fig. 7D).
Autophagy is increased in the lentiform nucleus of
asphyxiated human term newborns
We subsequently investigated whether neuronal autophagy was
enhanced in brains from asphyxiated human babies with HIE.
We focused our investigations on the lentiform nucleus, which
includes the putamen and the globus pallidus within the basal
ganglia, a region highly sensitive to HI in neonates. Cerebral
MRI diffusion-weighted imaging conﬁrmed that perinatal HI
led to induced severe and irreversible lesions in the cerebral
cortex and basal ganglia (Fig. 8A). Diffusion was severely
restricted, conﬁrming the presence of cytotoxic edema. Hema-
toxylin-eosin staining revealed the presence of pyknotic nuclei
and shrunken cells in the lentiform nuclei of all 7 HIE cases,
Figure 2. Neuronal Atg7 deﬁciency prevents neuronal basal autophagy and does not alter expression of mitochondria and cell death-related proteins. (A) Representative
immunoblotting of ATG7, SQSTM1, and LC3BB in the atg7 KO (Atg7ﬂox/ﬂox; Nes-Cre) and Ctrl (Atg7ﬂox/C; Nes-Cre) mice showing that ATG7 was strongly decreased in KO mice
leading to an accumulation of SQSTM1 and absence of LC3BB-II. (B) Representative immunostaining of SQSTM1 in the cortex of Ctrl and atg7 KO mice in the non-HI con-
trol condition, conﬁrming the accumulation of SQSTM1 in KO compared to the faint and diffuse expression in Ctrl. (C) Punctate and strong SQSTM1 staining was observed
in the cytoplasm of neuronal cells (RBFOX3) in the cortex of atg7 KO mice, but not in the Ctrl as shown by RBFOX3 and SQSTM1. (D) Representative immunoblots from
cortical tissue homogenates of P9 Ctrl and atg7 KO mice. Quantiﬁcation did not show any signiﬁcant differences between the 2 types of mice for cell death-related pro-
teins AIFM1, CYCS and CASP3, mitochondria-related proteins (SOD2, HSP70, CAT and mitochondrial respiratory chain complexes (COXV, COXIII, COXIV, COXII, COXI). (n D
6/group). KO: atg7 KO (Atg7ﬂox/ﬂox; Nes-Cre) and Ctrl: Atg7ﬂox/C; Nes-Cre.
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while such signs of cell death were rarely seen in controls. This
conﬁrmed the vulnerability of the human neonate basal ganglia
to HI (Fig. 8B).
The presence of autophagosomes was investigated by using
LC3B immunohistochemistry and by quantiﬁcation of the
number of LC3B-positive dots in the cytoplasm of individual
neurons in the lentiform nuclei. Each of the HIE cases dis-
played more neuronal LC3B-positive dots (autophagosomes)
than the control cases (Fig. 9A). On average, the number of
LC3B-positive dots was increased by 7-fold compared to con-
trols, indicating that HIE was accompanied by a considerable
induction of autophagosome formation in the lentiform nuclei.
To further conﬁrm that the increased number of autophago-
somes was a sign of enhanced autophagic ﬂux, tissues were
stained for the lysosomal markers LAMP1 (lysosomal-associ-
ated membrane protein 1) and CTSD (cathepsin D). Quantiﬁ-
cation of the number of LAMP1- (Fig. 9B) and CTSD-positive
dots (Fig. 9C) revealed an increase in all HIE cases compared
to controls and indicated a surge in lysosomal activity. Further-
more, 20% of the positive dots in the HIE cases were very large
lysosomes (>0.5 mm2, presumably autolysosomes), while these
made up less than 3% of the dots in control cases (Fig. 9D, E).
In order to conﬁrm that the increase in autophagosome and
lysosomal markers reﬂected an increase in autophagic ﬂux, we
ﬁnally investigated the expression of SQSTM1 (Fig. 9F). HIE
cases did not display an increase (or accumulation) in SQSTM1
staining compared to control cases, suggesting that autophagic
ﬂux is not impaired in HIE cases. Altogether, these results
strongly suggest that perinatal asphyxia increases neuronal
autophagy in the lentiform nuclei of human newborns, as
observed in P9 hypoxic-ischemic mice.
Discussion
Previous studies on the role of autophagy in neonatal brain
injury have yielded conﬂicting results, and both inhibition and
induction of autophagy by pharmacological agents have been
shown independently to decrease the severity of brain injury in
rodents.20-22 Since both 3-methyladenine (3-MA) and rapamy-
cin have limited speciﬁcity for the regulation of autophagy,27-29
it is important to use more speciﬁc methods for inhibiting
autophagy,30 and the present approach, genetic KO of an
important Atg gene, such as Atg7, is arguably the most speciﬁc
method available. Here, we show that selective genetic deletion
of neuronal Atg7 in mice reduced neuronal cell death, leading
to decreased brain injury after severe HI. These results corrobo-
rate those of Koike and colleagues22 obtained in the hippocam-
pus in a milder HI model, and extend the conclusion of a lethal
role of HI-enhanced autophagy to other brain regions (cortex,
thalamus and striatum), which are highly vulnerable to HI in
neonates.
Autophagy is a lysosome-mediated intracellular catabolic
mechanism responsible for the bulk degradation and recy-
cling of damaged or dysfunctional cytoplasmic components
and is the only pathway for degrading intracellular organ-
elles.14 Inactivation of autophagy results in the accumula-
tion of cytoplasmic protein inclusion bodies leading to cell
injury and neurodegeneration. Thus, autophagy plays an
essential role in cell survival.31 Incomplete autophagy leads
to the accumulation of autophagosomes, and this also con-
tributes to physiological dysfunction.15,32 Nevertheless, the
role of autophagy can be different under physiological
(basal autophagy) and pathological conditions (induced
Figure 3. For ﬁgure legend, see next page.
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autophagy). Knockout mouse studies targeting Atg5 or Atg7
have demonstrated that neurons in the brain require at least
basal levels of autophagy for the maintenance of their func-
tion.14,15 However, the negative effect of Atg7 deﬁciency
only manifests after many weeks of life, meaning that P9
mice do not yet present any signs of neurodegeneration or
other abnormalities. This allowed us to use atg7 KO mice
for studying the role of induced autophagy in perinatal HI
brain injury.
Neuronal cell death after HI in the immature brain dis-
plays necrotic, apoptotic, autophagic, and various hybrid
morphological features.3 Even though some studies failed
to detect neuroprotection with caspase inhibitors in neona-
tal HI models,9,26 previous studies have shown that apo-
ptosis plays a prominent role in the development of
immature brain injury11,33 and that this involves both cas-
pase-dependent and -independent pathways.4,21,22,34,35 Fur-
thermore, the combined inhibition of both apoptotic
pathways provided additive protection against HI injury in
this model34 indicating that these pathways run parallel to
each other in neonatal HI. The functional relationship
between apoptosis and autophagy is complex, and these 2
processes can act synergistically or suppress each other
through their shared regulation by many of the same
molecular regulators, such as the BCL2 family of pro-
teins.30 Crosstalk between autophagic and apoptotic cell
death pathways has been demonstrated both in vitro and
in vivo.21 ATG7 knockdown in a cell line prevents CASP3
activation and cell death, indicating a proapoptotic func-
tion of ATG7.36,37 Interestingly, we found that neuron-spe-
ciﬁc Atg7 deﬁciency had no inﬂuence on the expression of
apoptosis-related proteins under physiological condition,
contrasting with the reduced activation of both caspase-
dependent and -independent apoptotic pathways under HI
conditions in P9 mice. This speaks in favor of a proapop-
totic function for ATG7 acting upstream of apoptosis
under pathological conditions36 and suggests that HI-
enhanced autophagy can partially mediate neuronal death
by this pathway. In fact we have previously demonstrated
that, in primary cortical neuron cultures, neuronal death
induced by classical apoptotic stimuli could be decreased
by autophagy inhibition (3-MA, ATG5 and ATG7 downre-
gulation) affecting both CASP3 activation and AIFM1
nuclear translocation.38 The precise mechanisms rendering
atg7 KO neurons resistant to HI insults need to be investi-
gated further. Such mechanisms might include effects of
atg7 KO on mitochondrial function, redox capacity or
other pathways that could be overactivated in response to
the autophagy defect. However, it cannot be excluded that
atg7 KO might prevent cell death by an autophagy-inde-
pendent effect, as has been reported for other ATGs.16,39
However, to our knowledge, such a role of Atg7 has not
been demonstrated thus far in neurons. Moreover, a recent
study targeting BECN1, another autophagic-related protein
involved in a different complex along the autophagy
machinery, using lentiviral vectors transducing shRNA has
also shown that inhibiting autophagy displayed neuropro-
tection after HI in neonatal rats.25
HI induces microglia activation and local inﬂammation,
exacerbating brain injury through the secretion of proinﬂam-
matory cytokines and chemokines. Thus, inhibition of inﬂam-
mation could provide neuroprotection. Our data show
suppressed microglia activation and inﬂammation after HI in
atg7 KO mice. Nonetheless, the precise cause-effect relationship
among these observations remains elusive, meaning that
reduced microglia activation inﬂammation might account for
tissue protection in Atg7-deﬁcient brains or vice versa. Auto-
phagy plays important roles in the regulation of immune and
inﬂammatory reactions through regulation of cytokine secre-
tion and recruitment of leukocytes to sites of injury.40 Further
studies are needed to elucidate if ablation of neuronal auto-
phagy may have direct effects on injury-induced inﬂammation
and microglia activation.
Mitochondria have multiple functions throughout brain
development, including mitochondrial biogenesis as part of
normal cellular respiration, mitochondrial fusion and ﬁssion
for maintenance of organelle function, mitophagy to control
mitochondrial quality, and regulation of cell death.41 The
immature brain is particularly susceptible to HI because of the
poorly developed antioxidant defense systems. In this study, we
found that Atg7 deﬁciency neither has any obvious effect on
mitochondrial function-related genes, nor on redox capacity in
the immature brain. This indicates that increased resilience to
HI was not mediated by enhanced mitochondrial function sec-
ondary to the autophagy deﬁciency, and that further investiga-
tions are needed to elucidate the underlying mechanism.
Neuronal autophagy is enhanced in the basal ganglia of
human severely asphyxiated newborns. Dying neurons in
the lentiform nuclei of human HIE cases displayed strong
autophagic features (numerous autophagosomes and autoly-
sosomes) compared to control cases who did not display
enhanced autophagy and neuronal death. Moreover, the
level of SQSTM1, which is inversely correlated with auto-
phagic activity, was reduced in human brains, indicating
that autophagic ﬂux (both autophagosome formation and
lysosomal degradation) was induced.
In conclusion, the precise mechanisms by which atg7 KO
neurons resist HI need to be investigated in further detail.
Figure 3. (See previous page) Neuronal Atg7 deﬁciency reduced hypoxia-ischemia-induced neuronal autophagy and brain injury. (A) Representative immunoblots of
LC3BB from non-HI control (Cont) and HI ipsilateral (IL) hemispheres of Ctrl and atg7 KO mice 24 h after HI and the corresponding quantiﬁcation of LC3BB-II showed that
Atg7 deletion completely prevented HI-induced LC3BB-II increase, (P < 0.05, n D 6/group). (B) Representative MAP2 staining in the ipsilateral hemisphere of the hippo-
campus (left) and striatum (right) level with the indication of MAP2 negative areas. (C) Representative MAP2 staining of coronal brain sections 8 d after HI at the levels of
the dorsal hippocampus (left panels) and striatum (right panels) from Ctrl and atg7 KO mice and (D) measure of total tissue loss volume demonstrated a strong reduction
of the lesion in the atg7 KO mice (Ctrl: n D 38, atg7 KO: n D 28), (, P < 0.01). (E) Pathological scores performed in the cortex (Cx), hippocampus (Hip), striatum (Str),
and thalamus (Tha) conﬁrmed the greater resistance of atg7 KO mice compared to Ctrl mice, , P < 0.01. (F) There was no difference in the neuroprotection provided by
Atg7 deletion between males (Ctrl: n D 22, atg7 KO: n D 16) and females (Ctrl: n D 16, atg7 KO: n D 12) (, P < 0.05). (G) The neuronal cell architecture in the Ctrl and
atg7 KO mice in non-HI control and 24 h after HI indicated that dying neurons with condensed chromatin were more frequent in Ctrl than in atg7 KO. Squared areas are
enlarged in the right panels. Moreover, the neuronal architecture was relatively well preserved in the atg7 KO mouse compared to that of the Ctrl mice. KO: atg7 KO
(Atg7ﬂox/ﬂox; Nes-Cre) and Ctrl: Atg7ﬂox/C; Nes-Cre.
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Nonetheless, our ﬁndings suggest that transient and speciﬁc
autophagy inhibition could be a promising strategy that
should be developed experimentally in the hope of improv-
ing the outcome of perinatal asphyxia.
Materials and methods
Atg7 mice breeding and genotyping
FloxedAtg7mice were characterized previously15 and were crossed
with a Nes-Cre-driven line to produce Atg7ﬂox/ﬂox; Nes-Cre knockout
(atg7 KO) and Atg7ﬂox/C; Nes-Cre control mice (Ctrl). Genomic
DNA was isolated from tail samples according to the
Figure 4. Neuronal Atg7 deﬁciency reduced hypoxia-ischemia-induced neuronal
cell death. (A) Representative Fluoro-Jade (FJ) staining 24 h after HI and the corre-
sponding quantiﬁcations of the number of FJ-positive cells (B) in the border zone
of the cortical infarction (Cx) (2,093,000 § 287,600/mm3 vs. 1,259,000 § 230,200/
mm3; , P<0.05), (C) in the striatum (Str) (1,368,000 § 46,860/mm3 vs. 912,300 §
134,100/mm3; , P < 0.01), (D) in the entire CA1 (209,900 cells § 14,600 cells/
mm3 vs. 167,500 cells§ 12,310 cells/mm3; , P< 0.05) and (E) in the dentate gyrus
(DG) (500,700 cells § 56,880 cells/mm3 vs. 344,000 cells § 45,150 cells/mm3; , P
< 0.05, n D 11/group). KO: atg7 KO (Atg7ﬂox/ﬂox; Nes-Cre) and Ctrl: Atg7ﬂox/C; Nes-Cre. Figure 5. For ﬁgure legend, see next page.
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manufacturer’s instruction (Qiagen, 69506). The following primer
sets were used for genotyping: for the Cre transgene (Cre-S:cre
sense 55) 50-TTT GCC TGC ATT ACC GGT CGA TGC AAC-30
and (Cre-As:Cre AS1000) 50-TGC CCC TGT TTC ACT ATC
CAG GTT ACG GA-30 and for the Ctrl and Atg7ﬂox alleles (Hind-
Fw) 50-TGG CTG CTA CTT CTG CAA TGA TGT-30 and (Pst-
Rv) 50-CAG GAC AGA GAC CAT CAG CTC CAC-30. The reac-
tion mixture for genotyping contained 1 mL of genomic DNA,
0.2 mM dNTP, 2.5 mL 10£ PCR buffer (250 mM Tris-HCl, pH
8.3, 375 mM KCl, 15 mM MgCl2, all from Sigma), 1 U of Taq
DNA Polymerase (Sigma, D1806), and 0.5 mM of primer. The
PCR parameters were 98C for 20 s, 64C for 30 s, and 72C for
90 s for 30 cycles. PCR products were separated on a 1.5% agarose
gel containing SYBR Green. A 100-base pair (bp) ladder was used
to verify the size of the PCR products. The gels were imaged with
an LAS 3000 cooled CCD camera (Fujiﬁlm, Tokyo, Japan). atg7
KO mice were identiﬁed by the presence of both 500 bp and
1000 bp DNA bands. Ctrl mice were identiﬁed by the presence of
500 bp, 1000 bp, and 1500 bp products.
Hypoxia-ischemia
Postnatal d 9 (P9) atg7 KO and Ctrl mice of either gender were
anesthetized with isoﬂurane (5% for induction, 1.5% to 2.0%
for maintenance) in a 1:1 mixture of nitrous oxide and oxygen,
and the duration of anesthesia was less than 5 min. The left
common carotid artery was cut between double ligatures of
Prolene sutures (6.0). After the surgical procedure, the wounds
were inﬁltrated with lidocaine for local analgesia. The pups
were returned to their cages for 1 h and then placed in a cham-
ber perfused with a humidiﬁed gas mixture (10% oxygen in
nitrogen) for 50 min at 36C. Following hypoxic exposure, the
pups were returned to their cages. Control pups were not sub-
jected to HI. Mice were maintained in the Laboratory for
Experimental Biomedicine of Gothenburg University. All
experiments were performed in accordance with international
guidelines and approved by the Gothenburg Committee of the
Swedish Animal Welfare Agency (application no. 145-2008).
Human newborn brain specimens
Brain tissue was obtained from 13 autopsied human newborns
(Institute of Pathology, University of Lausanne) who died after
birth due to severe HIE (n D 7). Control cases (n D 6) were
newborns with conditions incompatible with life whose autop-
sies did not indicate brain injury. Most of the perinatal data
from the 2 groups, such as birth weight, gestational age, Apgar
score, time of death or resuscitation score, did not show statisti-
cal differences. As expected, there was signiﬁcantly greater met-
abolic acidosis in the HIE cases as reﬂected by a lower umbilical
artery pH, and all HIE cases experienced postnatal seizures
compared to none in the control group. Histological and
immunohistological analysis of the control brains revealed very
rare dying cells (pyknotic nuclei and shrunken cells, CASP3-
and TUNEL-positive cells). Selection was made retrospectively
from the death reports of the neonatology unit between 2001
and 2009. Autopsies were performed for medical and legal rea-
sons, and the tissue was ﬁxed within 12 h following death.
Informed consent for tissue collection was obtained from the
parents, and the local ethical committee approved the use of
the anonymized specimens. After ﬁxation in 10% buffered for-
malin for 3 wk, the samples were embedded in parafﬁn and 3-
mm thick sections were cut. MRI was available for 4 out of 7
HIE cases. Diffusion-weighted images were acquired using
spin-echo echo-planar imaging (SE-EPI), with 5-mm thick sli-
ces (b values: 0, 500, 1000 mm2/s) and multivoxel proton spec-
troscopy focused on the basal ganglia and thalamus.
Immunohistochemistry
The animals were deeply anesthetized with phenobarbital and
perfusion-ﬁxed with 5% formaldehyde in 0.1 M phosphate-
buffered saline (PBS; Gibco, 18912-014) followed by immersion
ﬁxation in the same ﬁxative for 24 h at 4C. After dehydration
with graded ethanol and xylene, the brains were parafﬁn-
embedded, serial cut in 5-mm coronal sections, and mounted
on glass slides. Every 100th section was stained for MAP2
(microtubule-associated protein 2) (1:1000, Sigma, M4403) for
brain injury evaluation (with a distance of 500 mm between sli-
ces). The sections were stained for the following cell death-
related markers: AIFM1, and active CASP3 as described previ-
ously.11 Three adjacent sections with an interval of 250 mm
were selected from hippocampal and striatum level from each
brain for each cell death-related marker staining. Sections were
deparafﬁnized and rehydrated, and antigen retrieval was per-
formed by heating the sections in 10 mM boiling sodium citrate
buffer (pH 6.0) for 10 min. Nonspeciﬁc binding was blocked for
30 min with 4% goat (Vector Laboratories, S-1000) or horse
(Vector Laboratories, S-2000) or donkey serum (Jackson
ImmunoResearch, 118135) (depending on the species used to
raise the secondary antibody) in PBS. Rabbit anti-active CASP3
(1:100, BD Pharmingen, 559565), goat anti-AIFM1/AIF (1:100,
2 mg/ml, Santa Cruz Biotechnologies, sc-9416), rabbit
anti- SQSTM1 (1:200, Enzo Life Science, BML-PW9860), rabbit
anti-AIF1/IBA1 (1:500, Wako, 019-19741), were incubated for
60 min at room temperature followed by the appropriate bioti-
nylated horse anti-goat (1:200, for AIFM1; Vector Laboratories,
BA-9500), goat anti-rabbit (1:250, for active CASP3, SQSTM1;
Vector Laboratories, BA-1000) secondary antibody for 60 min
at room temperature. Endogenous peroxidase activity was
Figure 5. (See previous page) Neuronal Atg7 deﬁciency decreased CASP3 activation after hypoxia-ischemia. (A) Representative active CASP3/caspase-3 staining 24 h after
HI and the corresponding quantiﬁcations of the number of CASP3-positive cells (B) in the cortex (Cx) (81,630 § 7,671/mm3 vs. 51,210 § 11,970/mm3; , P < 0.05), (C) in
the striatum (Str) (132,800 § 5,368/mm3 vs. 47,350 § 13,110/mm3; , P < 0.001), (D) in the CA1 (41,810 cells § 3,243 cells/mm3 vs. 22,860 cells § 4,685 cells/mm3; ,
P < 0.01) and (E) dentate gyrus (DG) (214,000 cells § 14,700 cells/mm3 vs. 144,000 cells § 23,940 cells/mm3; , P < 0.05, n D 11/group). (F) CASP3 enzymatic activity
24 h after HI was 50% lower in the ipsilateral (IL) hemisphere of atg7 KO mice than in Ctrl (n D 10 for Ctrl, n D 6 for atg7 KO). There was no difference in the nonischemic
control brains (Cont) (n D 13 for Ctrl and n D 6 for atg7 KO) or in the contralateral (CL) hemispheres (n D 10 for Ctrl, n D 6 for atg7 KO). (G) Representative SPTAN1/
a-fodrin (240 kDa) western blots from control (Cont) and ipsilateral (IL) hemispheres 24 h after HI and (H) the quantiﬁcation of the caspase-dependent 120 kDa break-
down products conﬁrmed that CASP3 activation was more pronounced in the Ctrl mice. (, P < 0.05, n D 6/group). KO: atg7 KO (Atg7ﬂox/ﬂox; Nes-Cre) and Ctrl: Atg7ﬂox/C;
Nes-Cre.
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blocked with 3% H2O2 for 5 min. Visualization was performed
using Vectastain ABC Elite (Vector Laboratories, PK-6200)
with 0.5 mg/mL 3,30-diaminobenzidine (Sigma-Aldrich,
D5637-25G) enhanced with 15 mg/mL ammonium nickel sul-
fate (Sigma-Aldrich, A1827-500G), 2 mg/mL b-D glucose
(Chemtronica, G0047), 0.4 mg/mL ammonium chloride, and
0.01 mg/mL b-glucose oxidase (Sigma, G2133-10KU). For the
double labeling of SQSTM1-RBFOX3/NeuN (1:200, Millipore,
MAB377), AIF1/IBA1-LGALS3 (5 mg/ml; eBioscience, 14–
5301), antigen recovery was performed as above followed by
incubation with the mixed antibodies in PBS at room tempera-
ture for 60 min. After washing, the sections were incubated
Figure 6. Neuronal Atg7 deﬁciency reduced hypoxia-ischemia-induced AIFM1
nuclear translocation. (A) Representative AIFM1 staining 24 h after HI and the cor-
responding quantiﬁcations of the number of AIFM1-positive nuclei (B) in the cortex
(Cx) (80,610 nuclei § 4,038 nuclei/mm3 vs. 49,060 nuclei § 6,115 nuclei/mm3; ,
P < 0.001), (C) in the striatum (Str) (59,610 nuclei § 2,322 nuclei/mm3 vs. 28,020
nuclei § 4,287 nuclei/mm3; , P < 0.001), (D) in the CA1 (45,620 nuclei § 3,849
nuclei/mm3 vs. 30,350 nuclei § 5,123 nuclei/mm3; , P < 0.05) and (E) dentate gyrus
(DG) (48,260 nuclei § 5,278 nuclei/mm3 vs. 30,730 nuclei § 4,294 nuclei/mm3; ,
P< 0.05). nD 11/group. KO: atg7 KO (Atg7ﬂox/ﬂox; Nes-Cre) and Ctrl: Atg7ﬂox/C; Nes-Cre.
Figure 7. Neuronal Atg7 deﬁciency attenuated hypoxia-ischemia-induced cytokine
and chemokine expression and microglial activation. (A) Luminex assay of the cyto-
solic fraction of nonischemic (Cont) (n D 9 for Ctrl and n D 7 for atg7 KO) and for
hypoxic-ischemic cortical tissue 24 h after HI (n D 9 for Ctrl and n D 7 for atg7 KO)
demonstrated a decreased IL6, CXCL1, CCL2 and IL1B in KO mice. (B) Representa-
tive AIF1 immunostaining in the cortex of both Ctrl and atg7 KO mice 24 h after HI.
(C) Double labeling of AIF1 and activated microglia marker galectin-3 (LGALS3) in
the HI cortex. (D) Quantiﬁcation of the number of AIF1-positive cells in both the
cortex (, P<0.05) and the striatum (, P<0.01) conﬁrmed a less pronounced
microglia activation in KO mice. (n D 11/group). KO: atg7 KO (Atg7ﬂox/ﬂox; Nes-Cre)
and Ctrl: Atg7ﬂox/C; Nes-Cre.
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with secondary antibodies at room temperature for 60 min. All
secondary antibodies were from Jackson ImmunoResearch
Laboratories and were diluted 1:1000 in PBS. After washing,
the sections were mounted using Vectashield mounting
medium.
In the human tissue, after deparafﬁnization and antigen
retrieval, the sections were blocked in PBS with 15% donkey
serum for 30 min and then incubated with primary antibodies
in 1.5% donkey serum overnight at 4C. The following primary
antibodies were used: rabbit anti-LC3B (Abcam, ab48394); goat
anti-CTSD (Santa Cruz Biotechnology, sc-6486), mouse anti-
LAMP1 (BD Biosciences, 611042) and rabbit anti-SQSTM1
(Sigma-Aldrich, P0067). Sections were then incubated with sec-
ondary antibodies, Alexa Fluor 594 donkey-anti-rabbit IgG
(HCL) (Invitrogen, A-21207), Alexa Fluor 488 donkey anti-
mouse IgG (HCL) (Invitrogen, A-21202), and Alexa Fluor 594
donkey-anti-goat IgG (HCL) (Invitrogen, A-11058). After sev-
eral washes in PBS and Hoechst staining, the sections were
then mounted using FluorSave medium (Calbiochem, 345789).
Fluoro-jade B staining
After deparafﬁnization, the sections were incubated with
freshly prepared 0.06% potassium permanganate for 10 min
and rinsed with distilled water. The slides were then incubated
with 0.001% Fluoro-Jade B solution (Chemicon, AG310) for
30 min at room temperature. After rinsing with distilled water,
the slides were dehydrated with ethanol and placed in xylene
for 2 min and covered with mounting medium.
Electron microscopy
The pups were deeply anesthetized with pentobarbital and ﬁxed
by cardiac perfusion with 2% paraformaldehyde-2% glutaralde-
hyde buffered with 0.1 mol/L phosphate buffer for ordinary
electron microscopy at 24 h after HI (n D 3/group). Samples
were cut into 1 mm thick coronal slices and post-ﬁxed with 2%
OsO4 with 0.1 mol/L phosphate buffer, block-stained in 1%
aqueous uranyl acetate, dehydrated with a graded series of alco-
hol, and embedded in Epon 812 (TAAB, T204). Silver sections
were cut with an ultramicrotome, stained with uranyl acetate
and lead citrate, and observed with an electron microscope
(HT7700, Hitachi, Tokyo, Japan). The pyknotic neurons and
total neurons were counted per visual ﬁeld and ratio of
pyknotic neurons was calculated.
Immunoblotting
Animals were sacriﬁced by decapitation at 24 h after HI. Con-
trol animals were sacriﬁced at the same time as HI pups. The
brains were rapidly dissected out on a bed of ice. The parietal
cortex (including the hippocampus) was dissected out from
each hemisphere and immediately frozen in liquid nitrogen
and stored at ¡80C. The samples were sonicated by adding
ice-cold isolation buffer (15 mM Tris-HCl, pH 7.6, 320 mM
sucrose, 1 mM DTT, 1 mM MgCl2, 3 mM EDTA-K, 0.5% pro-
tease inhibitor cocktail (Sigma, P8340), 1% phosphatase inhibi-
tor cocktail 1 (Sigma, P2850), and 1% phosphatase inhibitor
cocktail 2 (Sigma, P5726). The homogenates were centrifuged
at 9200 £ g for 15 min at 4C producing a pellet that included
nuclear, mitochondrial, and synaptosomal fractions and a
crude cytosolic fraction in the supernatant. The pellet fractions
were washed in homogenizing buffer and centrifuged at 9200
£ g for 15 min. The protein concentrations were determined
with the BCA protein assay adapted for microplates. Samples
with a volume of 65 mL were mixed with 25 mL NuPAGE LDS
4£ sample buffer (ThermoFisher Scientiﬁc, NP0007) and
10 mL reducing agent (ThermoFisher Scientiﬁc, NP0004) and
heated at 70C for 10 min. Individual samples were run on 4–
12% NuPAGE Bis-Tris gels (Novex, NP0323Box) and
Figure 8. Lentiform nucleus of asphyxiated human term newborns is highly vulnerable. (A) Magnetic resonance (MR) diffusion-weighted images with ADC maps (top
panel) of hypoxic-ischemic encephalopathy (HIE) case 1 (left) at 36 h of life and HIE case 7 (right) at 23 h of life showed bilateral restricted diffusion in the basal ganglia
(mainly in the putamen, arrowheads) and thalamus (long arrows) as well as in the cortex of case 7 (dashed arrows). MR multivoxel proton spectroscopy of HIE case 7
showing a negative double lactate peak at 1.2 ppm indicating an acute energy failure in this region (white arrow) at 23 h of life (lower panel). (B) Representative hematox-
ylin-eosin staining of the lentiform nucleus region showed the presence of numerous dying neurons (cell shrinkage and pyknotic nuclei, arrow) in newborns subjected to
perinatal asphyxia but not in controls (Ctrl).
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transferred to reinforced nitrocellulose membranes. After
blocking with 30 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.1%
Tween 20 (Merck, S4733984) containing 5% fat-free milk pow-
der for 60 min at room temperature, the membranes were incu-
bated with the following primary antibodies: rabbit anti-actin
(1:200; Sigma, A2066), mouse anti-SPTAN1/a-FODRIN
(0.2 mg/mL; clone AA6, BIOMOL, FG6090), rabbit anti-LC3B
(1:1000; Cell Signaling Technology, 2775), rabbit anti-SQSTM1
(1:1000; Enzo Life Science, PW9860), rabbit anti-ATG7
(1:1000; Cell Signaling Technology, 8558), goat anti-AIFM1
(1:1000, Santa Cruz, sc-9416), mouse anti-CYCS (1:500, BD
Pharmingen, 556433), rabbit anti-CAYP3 (1:1000, Santa Cruz,
sc-7148), mouse anti-CT (1:1000, Frontier Lab Ltd., LF-
MA0010); mouse anti-SOD2 (1:2000, Lab Frontier), mouse
anti-HSP70 (1:500, Santa Cruz, sc-7298), or mouse total
OXPHOS rodent western blotting WB antibody cocktail
(COXV, ab14748, COXIII, ab14745, COXIV, ab14705, COXII,
ab 14714, COXI, ab110242) (0.5 mg/mL, Abcam, MS604) at
room temperature for 60 min. After washing, the membranes
were incubated with a peroxidase-labeled secondary antibody
for 30 min at room temperature (goat anti-rabbit, 1:2,000,
horse anti-goat, 1:2,000, or horse anti-mouse 1:4,000; Vector
Figure 9. Neuronal autophagy is enhanced in the lentiform nucleus of asphyxiated human term newborns. (A) Representative confocal images of LC3B staining (red) in
neurons in the lentiform nuclei of human newborns, and quantiﬁcations of the numbers of LC3B-positive dots per neuron per mm2 (left histogram) in 6 controls (Ctrl)
and 7 hypoxic-ischemic encephalopathy (HIE) cases, showing an increase in autophagosome in all HIE cases. Right histogram showed the average numbers of LC3B-posi-
tive dots of control (0.021 § 0.007) and HIE (0.149 § 0.018) cases. Representative confocal images of (B) LAMP1 staining (green) and (C) CTSD staining (red) in lentiform
nuclei of human newborns and the quantiﬁcations of the numbers of positive dots per neuron per mm2 (left histograms) in the different cases individually demonstrated
an increase in lysosomes in all HIE cases. Right histograms showed the average numbers of positive dots of control (LAMP1: 0.046 § 0.005; CTSD: 0.035 § 0.004) and HIE
(LAMP1: 0.172 § 0.013; CTSD: 0.260 § 0.014). Quantiﬁcations showing the average percentages of (D) LAMP1- and (E) CTSD-positive dots larger than 0.5 mm2 per neuron
in control (LAMP1: 2.5§ 1.9%; CTSD: 2.6§ 1.8%) and HIE cases (LAMP1: 24.8§ 6.2%; CTSD: 19.8 § 3.6%). (F) Representative confocal images of SQSTM1 staining (green)
and CTSD (red) in neurons in human newborn lentiform nuclei showed that SQSTM1 expression was not increased (or accumulated) in neurons of HIE cases (right panels)
(, P<0.001).
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Laboratories, PI-1000, PtdIns-9500, PI-2000). Immunoreactive
species were visualized using the Super Signal West Dura sub-
strate (ThermoFisher Scientiﬁc, 34075) and an LAS 3000
cooled CCD camera (Fujiﬁlm, Tokyo, Japan). ACTIN was used
as the loading control.
RNA isolation and cDNA synthesis
Total RNA was isolated using the RNeasy mini kit (Qiagen,
74104) according to the manufacturer’s instructions. The con-
centration and purity of all RNA samples were determined
using a Nanodrop spectrophotometer (Nanodrop Technolo-
gies, Wilmington, USA). The integrity of RNA was measured
using ExperionTM RNA StdSens analysis kit (Bio-Rad,
7007103) on an Automated Electrophoresis Station machine
(Bio-Rad, Hercules, California, USA). One microgram of total
RNA was reverse transcribed using Reverse Transcription kit
(QuantiTect® Reverse Transcription kit; Qiagen, 205311).
Quantitative real-time PCR
Quantitative real-time PCR was performed using the LightCy-
cler 480 instrument (Roche Diagnostics, Mannheim, Germany)
and the SYBR Green (ThermoFisher Scientiﬁc, 0253) technique
according to the manufacturer’s instructions. The primers used
in the qPCR reactions were designed by Beacon Designer soft-
ware (PREMIER Biosoft). These primers are listed in Table S1.
The relative expression levels of mRNAs were calculated using
the method of geometric averaging of multiple internal control
genes.
Mitochondrial DNA copy measurement
Total DNA of cortex was isolated using a genomic DNA isola-
tion kit (Qiagen, 69506). The amount of mitochondrial DNA
relative to nuclear genomic DNA was determined by quantita-
tive real-time PCR. Two different genomic genes and mito-
chondrial genes were used for this purpose, The Ywhaz gene,
‘primers 50-GAGGAAGAATCGTGAGTTAGTT-30 (sense)
and 50-TGGTGATGGTTGAGACAGA-30(anti-sense), and the
Rplp0/36B4 gene, primers 50-GTTGTTAGCCTGTGATAGCA
¡30 (sense) and 50- CCGACCAGCAATGTTCTATT ¡30 (anti-
sense) from the genome; the mt-Nd4/ND4 gene, primers 50-
CCTCAGTTAGCCACATAGC ¡30 (sense) and 50-
GATTCGTTCGTAGTTGGAGTT ¡30 (anti-sense), and the D-
loop gene, primers 50- GCCCATGACCAACATAACTG ¡30
(sense) and 50- CCTTGACGGCTATGTTGATG ¡30 (anti-
sense) from mitochondria. The relative mitochondrial DNA
levels were calculated based on the threshold cycle (Ct) as
2¡D(DCt).
Glutathione reductase activity assay
Homogenized tissues were used for this activity assay. GSR
activity was measured using the Glutathione Reductase Activity
Colorimetric Assay Kit according to the manufacturer’s
instructions and expressed as mU/ml (BioVison, K761-200).
CASP3 activity assay
The protein concentrations were determined as above. Samples
of homogenate (40 mL) were mixed with 60 mL of extraction
buffer as described previously.42 Cleavage of Ac-DEVD-AMC
(Peptide Institute, 500329) was measured with an excitation
wavelength of 380 nm and an emission wavelength of 460 nm
and expressed as pmol AMC released per mg protein per
minute.
Cytokine and chemokine assay
Cytokines and chemokines were measured in whole-brain
homogenate supernatant fractions from P9 Ctrl and atg7 KO
mice at 24 h after HI and from P10 control mice. Samples were
prepared according to the protocol of the manufacturer. Pro-
tein concentration was measured with the BCA protein assay
and adjusted to 600 mg/mL with 0.5% bovine serum albumin
(Sigma, A2058). Levels of IL1A, IL1B, IL6, CXCL1, CCL2, and
TNF were simultaneously measured using the Bio-Plex Multi-
plex Cytokine Assay (Bio-Rad Laboratories, M60-009RDPD)
(Bio-Rad, Hercules, CA, USA). The results were normalized to
the amount of protein in the sample.
Injury evaluation
Brain injury was evaluated 8 d after HI based on total tissue loss
and neuropathological scoring. The MAP2-positive and -nega-
tive areas in each section were measured using Micro Image
(Olympus, Japan). The volume was calculated from the MAP2-
positive areas according to the Cavalieri principle using the fol-
lowing formula: V D SA £ P £ T, where V D total volume,
SA D sum of area measurements, P D the inverse of the sam-
pling fraction, and T D the section thickness (5 mm). The
MAP2-negative volume was the infarction volume. The total
tissue loss was calculated as the MAP2-positive volume in the
contralateral hemisphere minus the MAP2-positive volume in
the ipsilateral hemisphere. The neuropathological scores for the
cortex, hippocampus, striatum, and thalamus were assessed as
described previously.
Cell counting in mouse tissue
Area contours were drawn and measured in every 50th section.
The active CASP3¡, AIFM1C cells were counted at 400£ mag-
niﬁcation in the border zone of the injured cortex or striatum
within an area of 0.196 mm2 (one visual ﬁeld) as well as within
the whole CA and DG areas by using Micro Image (Olympus,
Japan). Fluoro-Jade-positive cells were counted by ﬂuorescence
microscopy. Three sections were counted from each brain with
an interval of 250 mm. The average was deﬁned as n D 1 when
comparing different brains. All of the counting was carried out
by investigators blinded to group assignment.
Quantiﬁcation of autophagic and lysosomal labeling of
human tissue
Confocal images of immunocytochemistry against LC3B,
CTSD, and LAMP1 were acquired with the same acquisition
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parameters on the confocal laser-scanning microscope (LSM
710 Meta confocal microscope, Carl Zeiss, Jena, Germany), and
images were processed with Adobe Photoshop 10.0. LC3B-,
CTSD-, and LAMP1-positive dots were quantiﬁed using Image
J software and expressed as the number of positive dots per
neuron per mm2. For CTSD- and LAMP1-positive dots, the dot
area was also quantiﬁed.
Statistics
All data were expressed as mean § s.e.m. The data distribution
normality was tested using the Shapiro–Wilk test. The Student
t test was used when comparing tissue loss. The Mann–Whit-
ney U-test was used to compare the numbers of immune-posi-
tive cells and injury scores between 2 different groups.
ANOVA with the Fisher post-hoc or multivariate test was used
when comparing more than 2 groups. The signiﬁcance level
was deﬁned as P < 0.05.
Abbreviations
AIF1/IBA1 allograft inﬂammatory factor 1
AIFM1/AIF apoptosis-inducing factor, mitochondria-
associated 1
Atg7 autophagy-related 7
bp base pair
CA cornu ammonis
CASP3 caspase 3
CAT catalase
CCL2 chemokine (C-C motif) ligand 2
CTSD cathepsin D
CXCL1/KC chemokine (C-X-C motif) ligand 1
CYCS/CYC cytochrome c, somatic
DG dentate gyrus
GSH glutathione
HI hypoxia-ischemia
HIE hypoxic-ischemic encephalopathy
HSP70 heat shock protein 70
IL interleukin
IL1A interleukin 1 alpha
IL1B interleukin 1 beta
IL6 interleukin 6
IL10 interleukin 10
KO knockout
LAMP1 lysosomal-associated membrane protein 1
LGALS3/galectin-3 lectin, galactoside-binding, soluble, 3
MAP1LC3B/LC3B microtubule-associated protein 1 light chain 3 beta
MAP2 microtubule-associated protein 2
P9 postnatal d 9
SOD2 superoxide dismutase 2, mitochondrial
SQSTM1/p62 sequestosome 1
TNF/TNFa tumor necrosis factor
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